试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-11
A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy
编号:NCT03474458登记状态:提前终止企业 / 申办者:Fondazione IRCCS Policlinico San Matteo di Pavia
药物 / 成分:Doxycycline、Standard of care therapy
登记的停止原因(原文):difficulty in recruitment
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-11
Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)
编号:NCT03526588登记状态:提前终止企业 / 申办者:The University of Texas Health Science Center, Houston
药物 / 成分:Autologous umbilical cord blood
登记的停止原因(原文):Competing randomized trial of an experimental therapy limited initial enrollment. The trial was completed, published, and the experimental therapy became broadly desired. Given this, the investigators felt it best to terminate this competing study.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-11
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)
编号:NCT04790903登记状态:提前终止企业 / 申办者:Hoffmann-La Roche
药物 / 成分:Venetoclax、Polatuzumab Vedotin、Rituximab、Cyclophosphamide
登记的停止原因(原文):Decision to discontinue the study based on broader development and strategic prioritisation. The Sponsor concludes there is no benefit-risk impact on the BO42203 study.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-11
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
编号:NCT05009953登记状态:提前终止企业 / 申办者:CSPC Ouyi Pharmaceutical Co., Ltd.
药物 / 成分:Irinotecan Liposome Injection、SG001、Fluorouracil、Leucovorin
登记的停止原因(原文):Internal strategy change. Not related to safety concerns.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-11
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
编号:NCT05604287登记状态:提前终止企业 / 申办者:IlDong Pharmaceutical Co Ltd
药物 / 成分:ID119031166M、Placebo
登记的停止原因(原文):Sponsor have decided to cancel the trial
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-10
Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
编号:NCT00838955登记状态:提前终止企业 / 申办者:Loyola University
药物 / 成分:Temsirolimus
登记的停止原因(原文):There was lack of enrollment since January 2013
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-10
Prucalopride Versus Placebo in Gastroparesis
编号:NCT02510976登记状态:提前终止企业 / 申办者:Universitaire Ziekenhuizen KU Leuven
药物 / 成分:prucalopride、placebo
登记的停止原因(原文):Prematurely stopped due to slow recruitment and expiry of study drug.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-10
Mast Cells in Acid-induced Intestinal Permeability
编号:NCT02664051登记状态:提前终止企业 / 申办者:Universitaire Ziekenhuizen KU Leuven
药物 / 成分:Nalcrom、placebo
登记的停止原因(原文):Inactive
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-10
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
编号:NCT02673229登记状态:提前终止企业 / 申办者:University of Kansas Medical Center
药物 / 成分:Collagenase Santyl、Bacitracin
登记的停止原因(原文):slow enrollment due to cost of medication and conflict of interest enrolling uninsured patients
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-07-10
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
编号:NCT02842580登记状态:提前终止企业 / 申办者:Federation Francophone de Cancerologie Digestive
药物 / 成分:5 FLUOROURACYL、acide folinique、irinotecan、Oxaliplatin
登记的停止原因(原文):Inclusion rythm too slow.
查看官方原始记录 ↗